Metabolic syndrome in pediatrics
Advances in Clinical Chemistry
|September 20, 2014
Summary
Childhood obesity is rising, leading to more pediatric metabolic syndrome (MS) cases. This review explores pediatric MS, focusing on new molecules and biomarkers in its development.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Cardiovascular Health
Background:
- Childhood obesity is increasing globally.
- Metabolic syndrome (MS) is increasingly diagnosed in children, a condition previously seen mainly in adults.
- MS in adults is linked to insulin resistance, hypertension, dyslipidemia, and increased cardiovascular disease risk.
Purpose of the Study:
- To review the unique characteristics of pediatric metabolic syndrome.
- To discuss the role of emerging molecules in the pathogenesis of pediatric MS.
- To explore novel biomarkers for identifying and managing pediatric MS.
Main Methods:
- Literature review of pediatric metabolic syndrome.
- Analysis of current research on molecular mechanisms in pediatric MS.
- Examination of novel biomarker studies relevant to pediatric metabolic syndrome.
Main Results:
- Pediatric MS shares similarities with adult MS but has distinct features.
- Specific molecular pathways are implicated in the development of pediatric MS.
- Emerging biomarkers show potential for early detection and risk stratification.
Conclusions:
- Pediatric MS is a growing concern requiring specific attention.
- Understanding novel molecular players is crucial for effective interventions.
- Biomarkers may offer new avenues for managing pediatric metabolic syndrome and preventing long-term complications.
More Related Videos
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
394
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
394
01:20Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
01:26Type II Diabetes I: Introduction
8
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
01:24Type II Diabetes II: Pathophysiology
8
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
8
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:24Overview of Lipid Metabolism
6.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.8K